Warby Parker Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Warby Parker Inc 's ROA in the second quarter of 2026?
Warby Parker Inc achieved a return on average assets (ROA) of 1.04 % in its second quarter of 2026, which is below Warby Parker Inc 's average return on assets, which stands at 4.86%.

ROA has improved compared to 0.19% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 201 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2514, from total ROA ranking in the first quarter of 2026 at 2882.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	16.71 %	7.86 %	42.61 %	42.32 %	45.81 %
Y / Y Net Income Change	-	-8.5 %	-	-	-
Net Income (TTM) in million	8	1	2	1	-9
Return On Assets (TTM)	1.04 %	0.19 %	0.23 %	0.11 %	-1.55 %
WRBY's Total Ranking	# 2514	# 2882	# 2539	# 2753	# 2860
Total Assets (TTM) in million	819	736	721	707	702
Seq. Total Assets Change	11.24 %	2.15 %	1.98 %	0.72 %	2.8 %
Seq. Net Income Change	46.18 %	-	-	-	-

WRBY's 5 Years Annual ROA >> Back to WRBY Management Effectiveness >> Compare WRBY ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 65
Sector	# 202
Overall	# 2176

Return On Assets Statistics
High	Average	Low
180.75 %	4.86 %	-40.89 %
(Dec 31 2021)		(Jun 30 2022)

Financial Statements
Warby Parker Inc 's Assets	$ 819 million	WRBY's Balance sheet
Warby Parker Inc 's Income	$ 5 million	Quarterly WRBY's Income Statement
WRBY's Income by Division		See WRBY's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	42.61 %	10.14 %	3.79 %	0.35 %	-
Total Assets in million	721	506	459	442	441
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	2	-20	-63	-110	-144
Annual Return On Assets	0.23 %	-4.03 %	-13.77 %	-24.96 %	-32.74 %

WRBY's 5 Years Annual ROA >> Back to WRBY Management Effectiveness >> Compare WRBY ROA to its Competitors

Comment on WRBY's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 0.23 % compared to prior year, due to annual net income growth of % to $1.64 million, while value of Warby Parker Inc 's overall assets grew just by 42.61 % to $720.92 million, compared to $720.92 a year before.

More Return On Assets Ratios
WRBY's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
WRBY's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for WRBY's Competitors
Subscribers only: Roa for Warby Parker Inc 's Suppliers
Subscribers only: Return On Assets for WRBY's Customers

You may also want to know
WRBY's Roi	WRBY's Inventory Turnover Ratio	WRBY's Growth Rates	WRBY's Dividend Comparisons
	WRBY's Profitability Ratios	WRBY's Asset Turnover Ratio	WRBY's Dividend Growth
WRBY's Roe	WRBY's Valuation Ratios	WRBY's Financial Strength Ratios	WRBY's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Collegium Pharmaceutical Inc	2.72 %
National Vision Holdings Inc	2.53 %
Conmed Corporation	2.44 %
Merck and Co Inc	2.42 %
Privia Health Group Inc	2.41 %
Lifestance Health Group Inc	2.33 %
Bio rad Laboratories Inc	2.21 %
Pfizer Inc	2.12 %
Mimedx Group Inc	1.99 %
Revvity Inc	1.97 %
Alkermes Plc	1.96 %
Becton Dickinson And Company	1.77 %
Teva Pharmaceutical Industries Limited	1.77 %
Immucell Corporation	1.76 %
Envista Holdings Corporation	1.69 %
Atricure Inc	1.62 %
Black Hawk Acquisition Corporation	1.56 %
Repligen Corp	1.41 %
Omada Health Inc	1.41 %
Arvinas Inc	1.29 %
Pacira Biosciences inc	1.17 %
Waters Corporation	1.12 %
Cormedix Inc	1.11 %
Warby Parker Inc	1.05 %
Surgery Partners Inc	1.02 %
Staar Surgical Co	0.84 %
Biomarin Pharmaceutical Inc	0.82 %
Icu Medical Inc	0.75 %
Lifemd Inc	0.65 %
Radnet Inc	0.50 %

Date modified: 2026-09-08T21:54:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.